Hemispherx Biopharma Announces US District Court Grants Final Approval of Settlement of Securities Class Actions

PHILADELPHIA, Feb. 17, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that the United States District Court for the Eastern District of Pennsylvania has issued an order granting final approval of a settlement of the currently pending securities class actions consolidated in the action In re Hemispherx Biopharma, Inc. Securities Litigation. In August 2010, the Company announced that it had received the Court's preliminary approval of the settlement of this litigation. The settlement will be paid from the Company's insurance coverage and will not result in the payment of any funds by the Company. Furthermore, the settlement expressly is not an admission of any culpability by Hemispherx or its officers.